Latest news
Outcomes in Early-Stage Triple-Negative Breast Cancer With Dose-Dense Doxorubicin and Cyclophosphamide as Part of Pembrolizumab-Based Regimens - Journal of Hematology Oncology PharmacyJournal of Hematology Oncology Pharmacy · Fri, 07 Aug 2026 16:18:45 GMTDoravirine-based HIV regimen shows less weight gain than dolutegravir combination, trial finds - Managed Healthcare ExecutiveManaged Healthcare Executive · Tue, 04 Aug 2026 19:07:52 GMTNCCN Guidelines Add Gedatolisib-Based Regimens for Pretreated PIK3CA Wild-Type Advanced Breast Cancer - OncLiveOncLive · Mon, 03 Aug 2026 15:13:18 GMTART Regimen Effective, Led to Less Weight Gain in Treatment-Naive HIV - MedPage TodayMedPage Today · Fri, 31 Jul 2026 17:29:08 GMT